Modified-release dosage

From WikiMD's WELLNESSPEDIA

(Redirected from Controlled-release)

Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage).

Mechanism of action[edit]

Modified-release dosage systems have a number of advantages over traditional dosage forms. They can reduce the frequency of dosing, improve patient compliance, and maintain steady drug plasma levels. This is achieved by controlling the rate, time, and place of release of drugs in the body.

Types of modified-release dosage[edit]

There are several types of modified-release dosage, including delayed-release dosage, extended-release dosage, and targeted-release dosage.

  • Delayed-release dosage involves delaying the release of the medication until it has passed through the stomach to avoid the drug being destroyed or inactivated by stomach acids.
  • Extended-release dosage involves the drug being released over an extended period, allowing for a reduction in frequency of dosing.
  • Targeted-release dosage involves the drug being released at a specific target in the body, improving the efficacy of the drug and reducing side effects.

Applications[edit]

Modified-release dosage forms are used in a number of therapeutic areas, including the treatment of chronic conditions such as diabetes, hypertension, and neurological disorders. They are also used in the treatment of pain, where sustained release of medication can provide better pain control.

Challenges[edit]

Despite the advantages, there are also challenges associated with the use of modified-release dosage forms. These include the complexity of drug formulation, the need for patient education to ensure correct use, and the potential for variable bioavailability.

See also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Modified-release_dosage&oldid=6309412"